Cencora Company Research Report

Company Overview

• Name of the company: Cencora

• Mission of the company: Cencora is committed to improving the lives of people and animals by providing innovative pharmaceutical solutions. The company aims to help create healthier futures for all by keeping customers, their patients, and team members at the center of everything it does.

• When was the company founded and by whom: Cencora’s history dates back to 1871, rooted in its foundation as a leader in pharmaceutical solutions derived from the legacy of AmerisourceBergen.

• Key people in the company: No information is available.

• Where is the company headquartered: No information is available.

• Number of employees: No information is available.

• Revenue of the company: No information is available.

• What is the company known for: Cencora is known for being a leading global pharmaceutical solutions organization. It is recognized for its comprehensive human and animal health solutions that emphasize energizing, inspiring, and confident healthcare approaches.

Products

• What products do they offer: Cencora offers a wide range of pharmaceutical distribution and biopharma services. It is particularly engaged in providing tools and strategies in human and animal healthcare sectors.

• High level description of the product: The company offers industry-leading solutions that accelerate better health outcomes from concept to delivery for global communities. It has solutions tailored for both human and animal health sectors, enabling optimization of operations, patient care, and client services.

• Key Features of each of the products:

• Human Health:

• Elevating patient care.

• Optimizing healthcare operations.

• Navigating evolving healthcare challenges.

• Animal Health:

• Managing operations and client experiences.

• Delivering top-notch animal pharmaceutical services.

• Leveraging global solutions for better health outcomes.

Recent Developments

• What are the recent developments in the company:

• As of October 2024, Cencora is participating in the White House Cancer Moonshot's New Pilot aimed at mitigating pediatric cancer drug shortages.

• In November 2024, the company advanced its specialty leadership by acquiring Retina Consultants of America.

• What are the new products launched:

• No information is available on new specific product launches.

• What are the new features added to the existing products:

• In March 2024, Cencora's MWI Animal Health added telehealth services to its AllyDVM Client Engagement Platform, enhancing its service platform's capabilities.

• Any new partnerships etc.: No specified new partnerships are mentioned.

Conclusion

Cencora, driven by a rich legacy from AmerisourceBergen, is focused on broad pharmaceutical solutions for both human and animal health. While detailed financial information and personnel specifics are not provided, Cencora's strategic involvements and service expansions illustrate its role as a leader in the pharmaceutical industry and commitment towards healthcare advancement.